Skip to main content
Erschienen in: Rheumatology International 12/2012

01.12.2012 | Original Article

Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters

verfasst von: Şefika Konca, Dilek Keskin, Deniz Cılız, Hatice Bodur, Bülent Sakman

Erschienen in: Rheumatology International | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Magnetic resonance imaging (MRI) has major contribution in early diagnosis of ankylosing spondylitis (AS). As it is difficult to determine disease activity owing to the lack of close relation between laboratory tests, clinical findings and imaging, MRI has been used as an objective outcome measure. The aim of this study is to investigate the relation between spinal MRI findings with disease activity and other outcome measures. Fifty patients fulfilling modified New York criteria for AS were enrolled to the study. All the patients were evaluated with Bath AS Disease Activity Index (BASDAI), AS Disease Activity Score (ASDAS), Bath AS Functional Index (BASFI), Bath AS Metrology Index (BASMI), Bath AS Radiology Index (BASRI) and As Quality of Life. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were measured as laboratory parameters, and ASspiMR scores were determined by spinal MRI. The median total ASspiMR-a score was 5.2. Spinal inflammation was evaluated in spinal segments, and thoracic segments had the highest mean ASspiMR-a level (3.1 ± 5.94). Cervical and lumbar ASspiMR were correlated with only BASRI, and total ASspiMR score was correlated with BASRI, BASMI and CRP. Thoracic ASspiMR score was correlated with patient’s and doctor’s global assessments, BASFI, BASMI, BASRI, ASDAS A, ASDAS B, ASDAS C, ASDAS D, ESR and CRP (P < 0.05). According to our results, the thoracic spine was the most related region with disease activity parameters and clinical outcome measures, so we suggest thoracic spine MRI evaluation in order to determine the disease activity.
Literatur
1.
Zurück zum Zitat Gensler L (2011) Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 5th edn. Mosby Elsevier, Philadelphia, pp 1129–1134CrossRef Gensler L (2011) Clinical features of ankylosing spondylitis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology, 5th edn. Mosby Elsevier, Philadelphia, pp 1129–1134CrossRef
2.
Zurück zum Zitat Braun J, Rudwaleit M, Hermann KG, Rau R (2007) Imaging in ankylosing spondylitis. Z Rheumatol 66:167–178PubMedCrossRef Braun J, Rudwaleit M, Hermann KG, Rau R (2007) Imaging in ankylosing spondylitis. Z Rheumatol 66:167–178PubMedCrossRef
3.
Zurück zum Zitat Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, Bollow M, Sieper J, Van Der Heijde D (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48:1126–1136PubMedCrossRef Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, Bollow M, Sieper J, Van Der Heijde D (2003) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 48:1126–1136PubMedCrossRef
4.
Zurück zum Zitat Wendling D, Toussirot E, Streit G, Prati C (2006) Imaging study scores for ankylosing spondylitis. Jt Bone Spine 73:655–660CrossRef Wendling D, Toussirot E, Streit G, Prati C (2006) Imaging study scores for ankylosing spondylitis. Jt Bone Spine 73:655–660CrossRef
5.
Zurück zum Zitat Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000–1008PubMedCrossRef Rudwaleit M, Khan MA, Sieper J (2005) The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 52:1000–1008PubMedCrossRef
6.
Zurück zum Zitat Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216–1223PubMedCrossRef Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216–1223PubMedCrossRef
7.
Zurück zum Zitat Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J (2009) The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1–44 Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J (2009) The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 68:1–44
8.
Zurück zum Zitat Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–284PubMedCrossRef Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N (2005) A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 25:280–284PubMedCrossRef
9.
Zurück zum Zitat Yanık B, Gürsel YK, Kutlay S, Ay S, Elhan AH (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24:41–47PubMedCrossRef Yanık B, Gürsel YK, Kutlay S, Ay S, Elhan AH (2005) Adaptation of the Bath Ankylosing Spondylitis Functional Index to the Turkish population, its reliability and validity: functional assessment in AS. Clin Rheumatol 24:41–47PubMedCrossRef
10.
Zurück zum Zitat Jenkinson TR, Mallorie PA, Whitelock HC (1994) Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatol 21:694–698 Jenkinson TR, Mallorie PA, Whitelock HC (1994) Defining spinal mobility in ankylosing spondylitis (AS): the Bath AS Metrology Index. J Rheumatol 21:694–698
11.
Zurück zum Zitat Madsen OR, Hansen LB, Rytter A, Suetta C, Egsmose C (2009) The bath metrology index as assessed by a trained and an untrained rater in patients with spondyloarthropathy: a study of intra- and inter-rater agreements. Clin Rheumatol 28:35–40PubMedCrossRef Madsen OR, Hansen LB, Rytter A, Suetta C, Egsmose C (2009) The bath metrology index as assessed by a trained and an untrained rater in patients with spondyloarthropathy: a study of intra- and inter-rater agreements. Clin Rheumatol 28:35–40PubMedCrossRef
12.
Zurück zum Zitat MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 41:2263–2270PubMedCrossRef MacKay K, Mack C, Brophy S, Calin A (1998) The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum 41:2263–2270PubMedCrossRef
13.
Zurück zum Zitat Tuncay Duruöz LD, Cerrahoglu L, Turan Y, Sari H (2008) Translation and validation of the Turkish version of the ankylosing spondylitis quality of life (ASQOL) questionnaire. Ann Rheum Dis 67(Suppl II):623 Tuncay Duruöz LD, Cerrahoglu L, Turan Y, Sari H (2008) Translation and validation of the Turkish version of the ankylosing spondylitis quality of life (ASQOL) questionnaire. Ann Rheum Dis 67(Suppl II):623
14.
Zurück zum Zitat Lukas C, Landewé R, Sieper J (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18–24PubMedCrossRef Lukas C, Landewé R, Sieper J (2009) Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis 68:18–24PubMedCrossRef
15.
Zurück zum Zitat Van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R, Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818PubMedCrossRef Van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, Braun J, Landewé R, Assessment of SpondyloArthritis international Society (ASAS) (2009) ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis 68:1811–1818PubMedCrossRef
16.
Zurück zum Zitat Lukas C, Braun J, van der Heijde D, Hermann KG, Rudwaleit M, Østergaard M, Oostveen A, O’Connor P, Maksymowych WP, Lambert RG, Jurik AG, Baraliakos X, Landewé R (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. ASAS/OMERACT MRI in AS Working Group. J Rheumatol 34:862–870PubMed Lukas C, Braun J, van der Heijde D, Hermann KG, Rudwaleit M, Østergaard M, Oostveen A, O’Connor P, Maksymowych WP, Lambert RG, Jurik AG, Baraliakos X, Landewé R (2007) Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment. ASAS/OMERACT MRI in AS Working Group. J Rheumatol 34:862–870PubMed
17.
Zurück zum Zitat Heikkilä S, Viitanen JV, Kautiainen H, Kauppi M (2002) Functional long-term changes in patients with spondyloarthropathy. Clin Rheumatol 21:119–122PubMedCrossRef Heikkilä S, Viitanen JV, Kautiainen H, Kauppi M (2002) Functional long-term changes in patients with spondyloarthropathy. Clin Rheumatol 21:119–122PubMedCrossRef
18.
Zurück zum Zitat Akdeniz O, Alaylı G, Tosun FC, Diren B, Cengiz K, Selçuk MB, Sünter T, Cantürk F (2008) Early spondyloarthropaty: scintigraphic, biological, and clinical findings in MR-positive patients. Clin Rheumatol 27:469–474PubMedCrossRef Akdeniz O, Alaylı G, Tosun FC, Diren B, Cengiz K, Selçuk MB, Sünter T, Cantürk F (2008) Early spondyloarthropaty: scintigraphic, biological, and clinical findings in MR-positive patients. Clin Rheumatol 27:469–474PubMedCrossRef
19.
Zurück zum Zitat Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216–1223PubMedCrossRef Baraliakos X, Davis J, Tsuji W, Braun J (2005) Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis before and after therapy with the tumor necrosis factor alpha receptor fusion protein etanercept. Arthritis Rheum 52:1216–1223PubMedCrossRef
20.
Zurück zum Zitat Baraliakos X, Hermann KG, Landewé R, Listing J, Golder W, Brandt J, Rudwailet M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 64:1141–1144PubMedCrossRef Baraliakos X, Hermann KG, Landewé R, Listing J, Golder W, Brandt J, Rudwailet M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison contrast enhanced T1 and short tau inversion recovery (STIR) sequences. Ann Rheum Dis 64:1141–1144PubMedCrossRef
21.
22.
Zurück zum Zitat Braun J, Baraliakos X, Golder W, Hermann KG, Listing J, Brandt J, Rudwaleit M, Zuehlsdorf S, Bollow M, Sieper J, van der Heijde D (2004) Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional X rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 63:1046–1055PubMedCrossRef Braun J, Baraliakos X, Golder W, Hermann KG, Listing J, Brandt J, Rudwaleit M, Zuehlsdorf S, Bollow M, Sieper J, van der Heijde D (2004) Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional X rays with magnetic resonance imaging using established and new scoring systems. Ann Rheum Dis 63:1046–1055PubMedCrossRef
23.
Zurück zum Zitat Sieper J, Baraliakos X, Listing J, Brandt J, Haibel H, Rudwailet M, Braun J (2005) Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology 44:1525–1530PubMedCrossRef Sieper J, Baraliakos X, Listing J, Brandt J, Haibel H, Rudwailet M, Braun J (2005) Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab. Rheumatology 44:1525–1530PubMedCrossRef
24.
Zurück zum Zitat Baraliakos X, Landewe R, Hermann KG, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Inflammation in ankylosing spondylitis: a systematic description of the extension and frequency of acute spinal changes using magnetic resonance imaging (MRI). Ann Rheum Dis 64:730–734PubMedCrossRef Baraliakos X, Landewe R, Hermann KG, Listing J, Golder W, Brandt J, Rudwaleit M, Bollow M, Sieper J, van der Heijde D, Braun J (2005) Inflammation in ankylosing spondylitis: a systematic description of the extension and frequency of acute spinal changes using magnetic resonance imaging (MRI). Ann Rheum Dis 64:730–734PubMedCrossRef
25.
Zurück zum Zitat Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69:1065–1071PubMedCrossRef Pedersen SJ, Sørensen IJ, Hermann KG, Madsen OR, Tvede N, Hansen MS, Thamsborg G, Andersen LS, Majgaard O, Loft AG, Erlendsson J, Asmussen K, Johansen JS, Jurik AG, Møller J, Hasselquist M, Mikkelsen D, Skjødt T, Hansen A, Ostergaard M (2010) Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis 69:1065–1071PubMedCrossRef
26.
Zurück zum Zitat Romero-Sánchez C, Robinson WH, Tomooka BH, Londoňo J, Valle-Oňate R, Huang F, Deng X, Zhang L, Yang C, Yu DT (2008) Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clin Rheumatol 27:1429–1435PubMedCrossRef Romero-Sánchez C, Robinson WH, Tomooka BH, Londoňo J, Valle-Oňate R, Huang F, Deng X, Zhang L, Yang C, Yu DT (2008) Identification of acute phase reactants and cytokines useful for monitoring infliximab therapy in ankylosing spondylitis. Clin Rheumatol 27:1429–1435PubMedCrossRef
27.
Zurück zum Zitat Puhakka KB, Jurik AG, Schiottz-Christensen B, Magnetic resonance imaging of sacroiliitis in early seronegative spondyloarthropathy et al (2004) Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) 43:234–237CrossRef Puhakka KB, Jurik AG, Schiottz-Christensen B, Magnetic resonance imaging of sacroiliitis in early seronegative spondyloarthropathy et al (2004) Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) 43:234–237CrossRef
Metadaten
Titel
Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters
verfasst von
Şefika Konca
Dilek Keskin
Deniz Cılız
Hatice Bodur
Bülent Sakman
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 12/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2248-5

Weitere Artikel der Ausgabe 12/2012

Rheumatology International 12/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.